Financials
Financial year 2025
PHARMA DMS from Roeselare, company number BE0821606232, closed financial year 2025 with a result of € 71,146 after tax. For that financial year PHARMA DMS recorded a gross margin of € 71,811 and equity of € 177,668. Compared with financial year 2024, the result moved from € 69,023 to € 71,146. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 177,668
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 71,146
▲ 3% vs 2024
Profit after tax over the fiscal year.
€ 221,582
▲ 12% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 71,000 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 83,778
Supplier invoices still open on the last day of the fiscal year.
€ 7,528
▲ 97% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 62,104 | € 67,897 | € 69,556 | € 71,811 | ▲ 3% |
| Profit after taxes | € 64,199 | € 68,736 | € 69,023 | € 71,146 | ▲ 3% |
| Equity | € 177,263 | € 177,500 | € 177,523 | € 177,668 | |
| Total debts | € 66,553 | € 70,197 | € 156,713 | € 177,619 | ▲ 13% |
| Cash | € 99,697 | € 104,655 | € 197,088 | € 221,582 | ▲ 12% |
| Retained profit | € 17,263 | € 17,500 | € 17,523 | € 17,668 | ▲ 1% |
| Dividend | € 64,000 | € 68,500 | € 69,000 | € 71,000 | ▲ 3% |
| Balance sheet total | € 243,817 | € 247,696 | € 334,236 | € 355,287 | ▲ 6% |
Key figures of PHARMA DMS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA DMS?
What happened at PHARMA DMS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 71,146 (▲ 3% vs 2024). Source: NBB ↗
- CORTEXCO BV became a director. NBB
- New establishment in Roeselare. KBO
- Start of the company according to the CBE. KBO
In short
From € 64,199 profit in 2022 to € 71,146 profit in 2025.
Paid € 220 in corporate taxes since 2022.
Best year ever: 2025, with € 71,146 profit.
Paid out € 272,500 in dividends to the owners in total.
Management
Behind PHARMA DMS is CORTEXCO BV. CORTEXCO BV is also behind Apotheek Vichte, Apotheek De Klokkeput, RCC PLAST, Westlaanapotheek and DERTIEN-ACHT.
Directors
According to the 2025 annual accounts
Director · represented by Tack Eveline
Also active at: Apotheek Vichte, Apotheek De Klokkeput, RCC PLAST, Westlaanapotheek, DERTIEN-ACHT
since 2015
Establishments
Establishment units
Physical locations of this company
Westlaan 138
8800 Roeselare
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0821.606.232
- VAT number
- BE 0821.606.232
- Registered office
- Westlaan 138, 8800 Roeselare
- Names & denominations
- PHARMA DMS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2009
- Peppol
- Active · Active since 3 Apr 2025
- Activities · NACE
Detailhandel in farmaceutische producten